When it comes to delays in delivery, Spahn said he could understand that such a “complex process as vaccine production can sometimes lead to problems,” but said that this should “affect everyone fairly and equally.” It is not, he said, about “EU first, but about Europe’s share, i.e. “Vaccines that leave the EU need a permit so that we at least know what is being manufactured, what is leaving Europe - and when it leaves Europe, whether there will be a fair distribution,” Spahn told ARD and ZDF. With all of this going on, Germany’s Federal Health Minister, Jens Spahn, has called for an export restriction for vaccines produced in the EU. Jens Spahn threatens to block vaccine exports Kyriakides said the EU “wants to know exactly which Aztrazeneca doses have been produced where, and whether and to whom they have been distributed.” The company has apparently not yet answered these questions satisfactorily, and the EU is suspicious that they may have supplied doses co-financed by the EU to other countries.
Talks with the EU fell apart on Monday, with the European Commissioner for Health and Food Safety, Stella Kyriakides, accusing AstraZeneca of providing “a lack of clarity and insufficient explanations.” She said the developers had to uphold “societal and contractual responsibilities” when it came to delivering vaccines.įurther discussions are scheduled for later in the week. The company’s vaccine against COVID-19 was set to be approved for use within the EU this week, on the understanding that the bloc would receive 100 million doses in the first quarter of 2021.īut the pharmaceutical company apparently “surprisingly” informed the European Commission on Friday that “reduced yields” in its supply chain meant it could only deliver around half of that, despite the fact that the bloc has made a large advance purchase and co-financed the development and subsequent production of the vaccine, to the tune of 336 million euros. AstraZeneca in the EU doghouse over vaccine shortfallĪstraZeneca stands accused of failing to give a satisfactory explanation for a huge shortfall in promised vaccine doses. The vaccine maker has also dismissed reports casting doubt on its efficacy for older patients. The EU has issued an angry warning to AstraZeneca after the pharma giant announced an unexpected delay in delivering millions of doses of its coronavirus vaccine to the bloc.
0 kommentar(er)
